Why New York approval could accelerate Quest Diagnostics’ Haystack MRD cancer strategy
Quest Diagnostics has taken Haystack MRD nationwide after New York approval. See how ctDNA testing could reshape cancer recurrence monitoring.
Medical Devices & Diagnostics